UNSPSC 51331901: Lithium carbonate

This classification denotes an antipsychotic agent with the molecular formula CO3.2Li, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2BMD2GNA4V, chemically known as lithium carbonate, rb2co3 but generally known as lithium carbonate, which bears US NIH Compound Identifier 767. European Medicines Agency schedules Lithium carbonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14375MIG. Most nations schedule lithium carbonate under HS 28369100 and SITC 52379.

As of Q4 2014, LITHIUM CARBONATE remains the US FDA Preferred Term for this commodity. Lithium carbonate bears US NLM identifiers UMLS ID C0085217 and NCI Concept Code C1318. SMILES: OC(=O)O.

UNSPSC 51331901 Lithium carbonate is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023—solicits naloxone and drug deactivation systems for community health initiatives, a pharmaceutical and public-safety application that does not map to lithium carbonate sourcing. The mismatch suggests either a tagging error on the county's part or that the code sees limited active use in state and local purchasing for its stated chemical commodity.

No recent opportunities bearing directly on lithium carbonate procurement appear in the current activity stream. State and local agencies sourcing this commodity should monitor energy storage, battery manufacturing, and specialty chemical procurement channels rather than expect regular solicitations under this code. The single available record does not support characterization of issuing-body type, geographic concentration, or representative use cases for the commodity itself.